Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Another Actos Lawsuit Filed

Filed November 28th, 2012 admin

The national law firm, Parker Waichman LLP, has filed a lawsuit alleging that use of the Type 2 diabetes drug, Actos, caused a North Carolina man to develop bladder cancer. The lawsuit accuses Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company of failing to warn consumers of the dangers associated with the drug.

The plaintiff has been permanently injured as the result of several years of Actos use and requires ongoing medical treatment, the lawsuit says. The suit also alleges loss of consortium on behalf of the man’s spouse.

The lawsuit was filed in the U.S. District Court for the Western District of Louisiana as part of the Actos multidistrict litigation (MDL). It states that the man started taking Actos in 2008 and suffered from bladder cancer around 2011. The suit claims that the bladder cancer was the byproduct of the defective nature of Actos and notes that studies have shown a link between Actos and an increased risk of bladder cancer. The lawsuit also accuses the defendants of knowing this association but failing to warn consumers of the risks.

Last summer, the U.S. Food and Drug Administration (FDA) issued an update to the Actos warning label to warn that the risk of bladder cancer increased significantly after one year of use. Meanwhile, the British Medical Journal published a study in May showing that the risk doubled in patients taking the drug for two years. Two months later, a study in the Canadian Medical Association Journal looked at data from over 2.6 million patients and found that Actos users were 22 percent more likely to develop bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!